Asia-Pacific Blood Culture Tests market is anticipated to grow at 9.21% CAGR from 2018 to 2023 and it is estimated that the Asia-Pacific market was valued at USD 11.27 billion in 2018 and is expected to reach USD 17.51 billion by 2023.
Blood culture tests are laboratory tests done to examine a blood sample for the presence of bacteria or any other microorganisms. According to World Health Organization, the global burden of infectious diseases accounts for 43%. High mortality and morbidity are associated with sepsis. This scenario demands for highly advanced blood culture tests to detect the disease-causing microorganisms which will aid in appropriate treatment.
The increase in the aging population with more need for blood tests is one of the major factors contributing to the development of this market. Rising incidences of blood infections, increasing prevalence of communicable diseases, advanced technologies, high demand for rapid diagnostic tests are few of the factors which are driving the growth of this industry. Moreover, the rising incidences of drug resistant strains of bacteria would further increase the demand for advanced blood culture tests. The major factors that hinder the growth of the blood culture tests market are the high costs associated with highly automated blood tests, stringent regulations for approval, scarcity of qualified healthcare professionals to work with the latest technologies, unsuitable reimbursement policies and the lack of awareness relating to the various technological advancements in the field.
The Asia-Pacific market is segmented on the basis Method, Product, Technology, Application and End User. On the basis of Method, it is segmented Automated and Manual. The conventional technique held the highest share in this market segment. The automated technique segment is expected to register the highest growth rate. On the basis of Product, it is segmented Consumables and Instrument. The consumables segment held the largest share in this market segment. The instruments segment is expected to witness the highest growth during the forecast period due to product advancements. On the basis of Technology, it is segmented culture-based, PCR, Microarray, and proteomic. The culture-based technology segment dominated the industry with the largest revenue share in this market segment. Molecular technology segment is anticipated to register the highest growth during the forecast period. On the basis of Application, it is segmented into Bacteremia and Fungemia. Bacterial infections segment dominated this segment of the market in terms of revenue in 2018. The bacterial infections segment is also anticipated to register the highest growth rate during the forecast period. On the basis of End User, it is segmented Hospital Laboratories and Reference Laboratories. The hospital laboratories accounted for the largest share in this market segment. Moreover, the hospital laboratories segment is expected to grow at the highest CAGR over the forecast period.
On the basis of geography, the market is analyzed under various regions namely India, China, Japan, South Korea and Australia. Asia Pacific region is projected to register the highest CAGR during the forecast period mainly due to the high occurrence of infectious diseases and developing healthcare infrastructure. There are many diagnostic companies that are targeting Asian countries like India and China, for business expansion. The presence of a large base of the target population and increase in the disposable income in the Asia Pacific region are some of the main factors aiding the market growth. Accessibility of advanced diagnostics products and presence of highly developed healthcare infrastructure have further fueled the growth market. Also, growing investments in R&D by manufacturers for new product development in this region is expected to propel the growth of the industry.
The market is dominated by companies like Becton, Dickinson and Company, bioMérieux SA, Thermo Fisher Scientific Inc., Cepheid, Inc., Nanosphere Inc., IRIDICA, Beckman Coulter, Bruker Corporation, and T2 Biosystems.
1.Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Product
5.1.1 Introduction
5.1.2 Consumables
5.1.2.3 Blood Culture Media
5.1.2.3.1 Aerobic Blood Culture Media
5.1.2.3.2 Pediatric Aerobic Blood Culture Media
5.1.2.3.3 Anaerobic Blood Culture Media
5.1.2.3.4 Mycobacterial Blood Culture Media
5.1.2.3.5 Fungi Blood Culture Media
5.1.2.4 Assay Kits & Reagents
"5.1.2.5 Blood Culture Accessories
"
5.1.3 Instruments
5.1.3.1 Automated Blood Culture Systems
5.1.3.2 Supporting Laboratory Equipment
5.1.3.2.1 Incubators
"5.1.3.2.2 Colony Counters
"
5.1.3.2.3 Microscopes
5.1.3.2.4 Gram Stainers
"5.1.4 Software and Services
"
5.1.5 Y-o-Y Growth Analysis, By Product
5.1.6 Market Attractiveness Analysis, By Product
5.1.7 Market Share Analysis, By Product
5.2 Technology
5.2.1 Introduction
5.2.2 Culture-Based Technology
5.2.3 Molecular Technologies
"5.2.3.1 Microarrays
"
5.2.3.2 PCR (Polymerase Chain Reaction)
5.2.3.3 PNA-FiSH (Peptide Nucleic Acid – Fluroscent in Situ Hybridization)
5.2.4 Proteomics Technology
5.2.5 Y-o-Y Growth Analysis, By Technology
5.2.6 Market Attractiveness Analysis, By Technology
5.2.7 Market Share Analysis, By Technology
5.3 Application
5.3.1 Introduction
5.3.2 Bacteremia
5.3.3 Fungemia
5.3.4 Mycobacterial Detection
5.3.5 Y-o-Y Growth Analysis, By Application
5.3.6 Market Attractiveness Analysis, By Application
5.3.7 Market Share Analysis, By Application
5.4 Method
5.4.1 Introduction
5.4.2 Manual Methods
5.4.3 Automated Methods
5.4.4 Y-o-Y Growth Analysis, By Method
5.4.5 Market Attractiveness Analysis, By Method
5.4.6 Market Share Analysis, By Method
5.5 End User
5.5.1 Introduction
5.5.2 Hospital Laboratories
5.5.3 Reference Laboratories
5.5.4 Academic Research Laboratories
5.5.5 Y-o-Y Growth Analysis, By End User
5.5.6 Market Attractiveness Analysis, By End User
5.5.7 Market Share Analysis, By End User
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Product
6.1.3.3 By Technology
6.1.3.4 By Application
6.1.3.5 By Method
6.1.3.6 End User
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Product
6.1.4.3 By Technology
6.1.4.4 By Application
6.1.4.5 By Method
6.1.4.6 End User
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Product
6.1.5.3 By Technology
6.1.5.4 By Application
6.1.5.5 By Method
6.1.5.6 End User
6.2 China
6.3 India
6.4 Japan
6.5 South Korea
6.6 Australia
7.Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 Becton, Dickinson and Company
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 BioMérieux SA
8.3 Thermo Fisher Scientific Inc.
8.4 Cepheid, Inc.
8.5 Nanosphere Inc.
8.6 IRIDICA
8.7 Beckman Coulter
8.8 Bruker Corporation
8.9 T2 Biosystems.
8.10 Abbott Laboratories
9.Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
